These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38549927)

  • 1. Case report: Targeted treatment strategies for Erdheim-Chester disease.
    Gulyás A; Pinczés LI; Mátyus J; Végh E; Bedekovics J; Tóth J; Barna S; Hunya Z; Szabó IL; Gazdag A; Illés Á; Magyari F
    Front Oncol; 2024; 14():1305518. PubMed ID: 38549927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.
    Asabella AN; Cimmino A; Altini C; Notaristefano A; Rubini G
    Hell J Nucl Med; 2011; 14(3):311-2. PubMed ID: 22087457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and positron emission tomography responses to long-term high-dose interferon-α treatment among patients with Erdheim-Chester disease.
    Cao XX; Niu N; Sun J; Cai H; Wang FD; Wang YN; Duan MH; Zhou DB; Li J
    Orphanet J Rare Dis; 2019 Jan; 14(1):11. PubMed ID: 30630516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vemurafenib for BRAF V600-Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis: Analysis of Data From the Histology-Independent, Phase 2, Open-label VE-BASKET Study.
    Diamond EL; Subbiah V; Lockhart AC; Blay JY; Puzanov I; Chau I; Raje NS; Wolf J; Erinjeri JP; Torrisi J; Lacouture M; Elez E; Martínez-Valle F; Durham B; Arcila ME; Ulaner G; Abdel-Wahab O; Pitcher B; Makrutzki M; Riehl T; Baselga J; Hyman DM
    JAMA Oncol; 2018 Mar; 4(3):384-388. PubMed ID: 29188284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual BRAF/MEK blockade restores CNS responses in BRAF-mutant Erdheim-Chester disease patients following BRAF inhibitor monotherapy.
    Mazor RD; Weissman R; Luckman J; Domachevsky L; Diamond EL; Abdel-Wahab O; Shapira S; Hershkovitz-Rokah O; Groshar D; Shpilberg O
    Neurooncol Adv; 2020; 2(1):vdaa024. PubMed ID: 32642685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Central diabetes insipidus in adult patients--the first sign of Langerhans cell histiocytosis and Erdheim-Chester disease. Three case studies and literature review].
    Adam Z; Balsíková K; Krejcí M; Pour L; Stĕpánková S; Svacina P; Hermanová M; Vanícek J; Krupa P; Stanícek J; Koukalová R; Neubauer J; Krivanová A; Mayer J; Hájek R
    Vnitr Lek; 2010 Feb; 56(2):138-48. PubMed ID: 20329585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of five years of treatment of Erdheim-Chester disease with anakinra: case report and overview of literature].
    Adam Z; Petrášová H; Řehák Z; Koukalová R; Krejčí M; Pour L; Vetešníková E; Čermák A; Ševčíková S; Szturz P; Král Z; Mayer J
    Vnitr Lek; 2016; 62(10):820-832. PubMed ID: 27900869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical spectrum of Erdheim-Chester disease: an observational cohort study.
    Estrada-Veras JI; O'Brien KJ; Boyd LC; Dave RH; Durham B; Xi L; Malayeri AA; Chen MY; Gardner PJ; Alvarado-Enriquez JR; Shah N; Abdel-Wahab O; Gochuico BR; Raffeld M; Jaffe ES; Gahl WA
    Blood Adv; 2017 Feb; 1(6):357-366. PubMed ID: 28553668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurologic and oncologic features of Erdheim-Chester disease: a 30-patient series.
    Bhatia A; Hatzoglou V; Ulaner G; Rampal R; Hyman DM; Abdel-Wahab O; Durham BH; Dogan A; Ozkaya N; Yabe M; Petrova-Drus K; Panageas KS; Reiner A; Rosenblum M; Diamond EL
    Neuro Oncol; 2020 Jul; 22(7):979-992. PubMed ID: 31950179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic involvement in Erdheim-Chester disease: a case report and review of the literature.
    Dai JW; He TH; Duan MH; Li Y; Cao XX
    BMC Gastroenterol; 2022 Jun; 22(1):302. PubMed ID: 35729495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal involvement in Erdheim-Chester disease: Multimodality imaging features and association with the BRAF
    Nikpanah M; Dehghani Firouzabadi F; Farhadi F; Mirmomen SM; Ahlman MA; Huda F; Millo C; Saboury B; Paschall AK; Gahl WA; Estrada-Veras JI; Turkbey E; Jones EC; O'Brien K; Malayeri AA
    Clin Imaging; 2024 Feb; 106():110067. PubMed ID: 38128404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dramatic Efficacy of Interferon and Vemurafenib on Psychiatric Symptoms Revealing
    Razanamahery J; Abdallahoui M; Chabridon G; Fromont A; Tarris G; Idbaih A; Comby PO; Godard F; Haroche J; Audia S; Bonnotte B
    Front Immunol; 2022; 13():918613. PubMed ID: 35874752
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Young JR; Johnson GB; Murphy RC; Go RS; Broski SM
    J Nucl Med; 2018 May; 59(5):774-779. PubMed ID: 29097410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Usefulness of nuclear medicine in Erdheim-Chester disease: A Lille experience].
    Adens A; Landy P; Terriou L; Baillet C; Beron A; Lambert M; Launay D; Huglo D
    Rev Med Interne; 2017 Apr; 38(4):235-242. PubMed ID: 28268124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The histiocytosis Erdheim-Chester disease is an inflammatory myeloid neoplasm.
    Haroche J; Cohen-Aubart F; Charlotte F; Maksud P; Grenier PA; Cluzel P; Mathian A; Emile JF; Amoura Z
    Expert Rev Clin Immunol; 2015; 11(9):1033-42. PubMed ID: 26197238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erdheim-Chester disease with bilateral orbital masses and multi-systemic symptoms: two case reports.
    Qiao J; Ma R; Peng X; He W
    World J Surg Oncol; 2023 Jul; 21(1):233. PubMed ID: 37525276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAF(V600E)-mutated Erdheim-Chester disease.
    Haroche J; Cohen-Aubart F; Emile JF; Maksud P; Drier A; Tolédano D; Barete S; Charlotte F; Cluzel P; Donadieu J; Benameur N; Grenier PA; Besnard S; Ory JP; Lifermann F; Idbaih A; Granel B; Graffin B; Hervier B; Arnaud L; Amoura Z
    J Clin Oncol; 2015 Feb; 33(5):411-8. PubMed ID: 25422482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pineal gland involvement in Erdheim-Chester disease detected on (18)F-FDG PET-CT imaging: a case report and review of literature.
    Mukherjee A; Dhull VS; Karunanithi S; Sharma P; Durgapal P; Kumar R
    Clin Imaging; 2014; 38(3):367-71. PubMed ID: 24461468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of 2-[
    Pudis M; Palomar-Muñoz A; Solanich-Moreno X; Robles-Barba JJ; Rocamora-Blanch G; Rodríguez-Bel L; Narváez JA; Cortés-Romera M
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2024; 43(1):14-22. PubMed ID: 37804884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.